Effects of α-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss

Obesity

Volumn 23, Issue 2, 2015, Pages 313-321

  Huerta, Ana E ^a   Navas Carretero, Santiago ^a,b   Prieto Hontoria, Pedro L ^a,b   Martínez, J Alfredo ^a,b   Moreno Aliaga, María J ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Facultad de Estudios del Patrimonio Cultural   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCOSE; ICOSAPENTAENOIC ACID; INSULIN; LEPTIN; LIPID; PLACEBO; THIOCTIC ACID; ANTIOXIDANT; CHOLESTEROL;

ABSENCE OF SIDE EFFECTS; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; CALORIC RESTRICTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY EXPENDITURE; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LOW CALORY DIET; MAJOR CLINICAL STUDY; MONOTHERAPY; MORNING DOSAGE; OBESITY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; RESTING ENERGY EXPENDITURE; SHORT COURSE THERAPY; WEIGHT REDUCTION; BLOOD; DRUG COMBINATION; DRUG EFFECTS; ENERGY METABOLISM; LIPID METABOLISM; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; ANTIOXIDANTS; BODY COMPOSITION; CHOLESTEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; ENERGY METABOLISM; FEMALE; GHRELIN; GLUCOSE; HUMANS; INSULIN; LEPTIN; LIPID METABOLISM; MIDDLE AGED; OBESITY; THIOCTIC ACID; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84922721859     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20966     Document Type: Article

References (40)

1. World Health Organization. Global status report on noncommunicable diseases 2010. Rome, Italy: World Health Organization; 2011.
2. Fernández-Galilea M, Prieto-Hontoria PL, Martínez JA, Moreno-Aliaga MJ,. Antiobesity effects of α-lipoic acid supplementation. Clin Lipidol 2013; 8: 371-383.
3. Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Barber A, Martínez JA, Moreno-Aliaga MJ,. Lipoic acid prevents body weight gain induced by a high fat diet in rats: Effects on intestinal sugar transport. J Physiol Biochem 2009; 65: 43-50.
4. Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Martínez JA, Moreno-Aliaga MJ,. Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats. Eur J Nutr 2012; 52: 779-787.
5. Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Martínez JA, Moreno-Aliaga MJ,. Lipoic acid inhibits leptin secretion and Sp1 activity in adipocytes. Mol Nutr Food Res 2011; 55: 1059-1069.
6. Wang Y, Li X, Guo Y, Chan L, Guan X,. alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabolism 2010; 59: 967-976.
7. Carbonelli MG, Renzo LD, Bigioni M, Daniele ND, Lorenzo AD, Fusco MA,. Alpha-lipoic acid supplementation: A tool for obesity therapy? Curr Pharm Des 2010; 16: 840-846.
8. Koh EH, Lee WJ, Lee SA, Kim EH, Cho EH, Jeong E, Kim DW, Kim MS, Park JY, Park KG, Lee HJ, Lee IK, Lim S, Jang HC, Lee KH, Lee KU,. Effects of alpha-lipoic Acid on body weight in obese subjects. Am J Med 2011; 124: 85.e1-85.e8.
9. Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Martínez JA, Moreno-Aliaga MJ,. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: A review of the evidence. J Physiol Biochem 2013; 69: 633-651.
10. Kunesova M, Braunerova R, Hlavaty P, Tvrzicka E, Stankova B, Skrha J, Hilgertová J, Hill M, Kopecký J, Wagenknecht M, Hainer V, Matoulek M, Parízková J, Zák A, Svacina S,. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res Acad Sci Bohemoslov 2006; 55: 63-72.
11. Thorsdottir I, Tomasson H, Gunnarsdottir I, Gisladottir E, Kiely M, Parra MD, et al. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes 2007; 31: 1560-1566.
12. DeFina LF, Marcoux LG, Devers SM, Cleaver JP, Willis BL,. Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr 2011; 93: 455-462.
13. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, Jebb SA,. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes 2006; 30: 1535-1544.
14. Mori TA, Woodman RJ,. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 2006; 9: 95-104.
15. Tishinsky JM, Ma DW, Robinson LE,. Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARgamma-dependent manner in human adipocytes. Obesity (Silver Spring). 2011; 19: 262-268.
16. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B Methodol 1995; 57: 289-300.
17. Ansar H, Mazloom Z, Kazemi F, Hejazi N,. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J 2011; 32: 584-588.
18. McNeilly AM, Davison GW, Murphy MH, Nadeem N, Trinick T, Duly E, Novials A, McEneny J,. Effect of alpha-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. Lipids Health Dis 2011; 10: 217.
19. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU,. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004; 10: 727-733.
20. Fernández-Galilea M, Pérez-Matute P, Prieto-Hontoria PL, Sáinz N, Lõpez-Yoldi M, Houssier M, Martínez JA, Langin D, Moreno-Aliaga MJ,. α-Lipoic acid reduces fatty acid esterification and lipogenesis in adipocytes from overweight/obese subjects. Obesity (Silver Spring) 2014; 22: 2210-2215.
21. Fernández-Galilea M, Pérez-Matute P, Prieto-Hontoria PL, Martínez JA, Moreno-Aliaga MJ,. Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes. J Lipid Res 2012; 53: 2296-306.
22. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, Kawano H, Yano T, Aoe S, Takeya M, Shimatsu A, Kuzuya H, Kamei Y, Ogawa Y,. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 2007; 27: 1918-1925.
23. Munro IA, Garg ML,. Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br J Nutr 2012; 3: 1-9.
24. Oster RT, Tishinsky JM, Yuan Z, Robinson LE,. Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARgamma mRNA, in 3T3-L1 adipocytes. Appl Physiol Nutr Metab 2010; 35: 783-789.
25. Pérez-Matute P, Marti A, Martínez JA, Fernández-Otero MP, Stanhope KL, Havel PJ, Moreno-Aliaga MJ,. Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: Role of glucose metabolism. Am J Physiol Integr Comp Physiol 2005; 288: R1682-R1688.
26. Pérez-Matute P, Pérez-Echarri N, Martínez JA, Marti A, Moreno-Aliaga MJ,. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: Role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 2007; 97: 389-398.
27. Hinkle W, Cordell M, Leibel R, Rosenbaum M, Hirsch J,. Effects of reduced weight maintenance and leptin repletion on functional connectivity of the hypothalamus in obese humans. PloS One 2013; 8: e59114.
28. Doucet E, St Pierre S, Alméras N, Mauriège P, Richard D, Tremblay A,. Changes in energy expenditure and substrate oxidation resulting from weight loss in obese men and women: Is there an important contribution of leptin? J Clin Endocrinol Metab 2000; 85: 1550-1556.
29. Munro IA, Garg ML,. Prior supplementation with long chain omega-3 polyunsaturated fatty acids promotes weight loss in obese adults: A double-blinded randomised controlled trial. Food Funct 2013; 4: 650-658.
30. Chang HM, Lee HJ, Park HS, Kang JH, Kim KS, Song YS, Jang YJ,. Effects of weight reduction on serum vaspin concentrations in obese subjects: Modification by insulin resistance. Obesity (Silver Spring) 2010; 18: 2105-2110.
31. Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, Azuma K, Itoh M, Yamamoto Y, Kamei Y, Horie M, Watada H, Ogawa Y,. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol 2008; 28: 2173-2179.
32. Egert S, Kannenberg F, Somoza V, Erbersdobler HF, Wahrburg U,. Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr 2009; 139: 861-868.
33. Kurabayashi T, Okada M, Tanaka K,. Eicosapentaenoic acid effect on hyperlipidemia in menopausal Japanese women. The Niigata Epadel Study Group. Obstet Gynecol 2000; 96: 521-528.
34. Hill AM, Buckley JD, Murphy KJ, Howe PR,. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr 2007; 85: 1267-1274.
35. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ,. Dietary fish as a major component of a weight-loss diet: Effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999; 70: 817-825.
36. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Hal NF, Ruzickova J, Sponarova J, Drahota Z, Vlcek C, Keijer J, Houstek J, Kopecky J,. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 2005; 48: 2365-2375.
37. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R,. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 trial. Diabetes Care 2006; 29: 2365-2370.
38. Ramel A, Martinez A, Kiely M, Morais G, Bandarra NM, Thorsdottir I,. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 2008; 51: 1261-1268.
39. Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ, Lewis F, Slaughter S, Cooper JA, Miller GJ, Griffin BA,. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: The OPTILIP Study. Am J Clin Nutr 2006; 84: 1290-1298.
40. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM,. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009; 1790: 1149-1160.